43rd week of 2011 patent applcation highlights part 52 |
Patent application number | Title | Published |
20110263863 | METHOD FOR THE PREPARATION OF TIZANIDINE HYDROCHLORIDE - The invention deals with a preparation method of salts of 5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole (tizanidine) of formula I, especially tizanidine hydrochloride, comprising preparation of a salt of tizanidine of formula I and a carboxylic acid as an intermediate, from which, after acidification with hydrogen chloride, tizanidine hydrochloride is obtained in a high yield and purity. | 2011-10-27 |
20110263864 | REGENERATION OF 2,2'-CYCLOPROPYLIDENE-BIS (OXAZOLINES) - The present invention provides a method for regeneration of chiral 2,2′-cyclopropylidene-bis(oxazolines), such as (3&R, 3′aR,8aS,8′aS)-2,2′-cyclopropylidenebis-[3a,8a]-dihydro-8H-indeno-[1,2-d]-oxazole and (45,4′5,5R,5′R)-2,2′-cyclopropy-lidenebis-4,5-diphenyldihydro-4,5-oxazole, used as a part of complex catalysts for e.g. stereoselective addition reactions, from the reaction mixtures, by selective sorption of 2,2′-cyclopropylidene-bis(oxazolines) on a sorbent, such as silica gel, isolation of the sorbent from reaction mixture, desorption of 2,2′-cyclopropylidene-bis(oxazolines) from the sorbent with suitable organic solvent and final recovery of 2,2′-cyclopropylidene-bis(oxazolines) from the organic solvent used for desorption process. Catalytic quality of recovered compounds does not differ from those in freshly prepared catalysts. | 2011-10-27 |
20110263865 | POLYMORPHS OF ZOLMITRIPTAN - The present invention provides a novel isopropyl acetate solvate form of zolmitriptan, and a process for its preparation thereof. The present invention also provides a process for preparation of zolmitriptan polymorph A. Thus, for example, zolmitriptan isopropanol solvate was dissolved in isopropyl acetate at 25 deg C, the contents were heated to reflux for 30 minutes and the separated solid was filtered, washed with isopropyl acetate to give zolmitriptan isopropyl acetate solvate. | 2011-10-27 |
20110263866 | PROCESS FOR PRODUCTION OF 3-[5-[4-(CYCLOPENTYLOXY)-2-HYDROXYBENZOYL]-2-[(3-OXO-2-SUBSTITUTED-2,3-DI- HYDRO-1,2-BENZISOXAZOL-6-YL)METHOXY]PHENYL]PROPIONATE ESTER AND INTERMEDIATE FOR THE PROCESS - A 6-(halomethyl)-1,2-benzisoxazol-3(2H)-one derivative represented by the formula: | 2011-10-27 |
20110263867 | METHODS FOR PRODUCTION OF 1,2,4-TRIAZOL-3-ONE - Novel methods for producing 1,2,4-triazol-3-one from semicarbazide hydrochloride and formic acid are provided. In methods of this invention, ethanol is used in removal of unreacted formic acid to increase yield and purity of produced 1,2,4-triazol-3-one. | 2011-10-27 |
20110263868 | NOVEL CRYSTALS AND PROCESS OF MAKING 5-(-METHYL)-2-METHOXY-BENZOIC ACID - The present invention relates to a novel crystals of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid and methods of making the zwitterion of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid. | 2011-10-27 |
20110263869 | METHODS FOR THE PREPARATION OF ARYL AMIDES - The present invention relates to methods of initiating a reaction represented by scheme (1), wherein Q is optionally substituted aryl or optionally substituted heteroaryl; X is halogen or a sulphonate; P is an organic radical; R is hydrogen or an organic radical; wherein the catalyst comprises copper and a ligand; comprising providing the compound of formula III in liquid form prior to contacting the compound of formula III with the catalyst. | 2011-10-27 |
20110263870 | NOVEL PYRROLE DERIVATIVES AND THEIR SYNTHESIS - The present invention relates to two novel pyrrole derivatives [3-Phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methylethyl)-pyrrole-1-yl]methyl(diphenyl)phosphine oxide and Diethyl [3-Phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methylethyl)-pyrrole-1-yl]methylphosphonate. These pyrrole derivatives can be used as intermediates for the synthesis of the anticholesterol drug atorvastatin. | 2011-10-27 |
20110263871 | METHOD FOR THE SYNTHESIS OF A RAMIPRIL INTERMEDIATE - The present invention relates to a process for the preparation of octahydrocyclopenta[b]pyrrole-2-carboxylic acid and esters thereof of general formula (1) in the presence of a cobalt and/or nickel comprising catalyst and to the use of compounds of general formula (1) in the synthesis of ramipril. | 2011-10-27 |
20110263872 | RADIOACTIVE ISOTOPE-LABELED DYE COMPOUND - A radioactive isotope-labeled dye compound represented by the following general formula (I): | 2011-10-27 |
20110263873 | Enantioselective Synthesis of y-amino-alpha beta-unsaturated carboxylic acid derivatives - Provided is an enantioselective, palladium-catalyzed method for the preparation of γ-amino-α,β-unsaturated carboxylic acid derivatives having the formulas II, III, VII and VIII: | 2011-10-27 |
20110263874 | Process for Producing Cyclic Compounds - The invention includes methods of processing an initial di-carbonyl compound by conversion to a cyclic compound. The cyclic compound is reacted with an alkylating agent to form a derivative having an alkylated ring nitrogen. The invention encompasses a method of producing an N-alkyl product. Ammonia content of a solution is adjusted to produce a ratio of ammonia to di-carboxylate compound of from about 1:1 to about 1.5:1. An alkylating agent is added and the initial compound is alkylated and cyclized. The invention includes methods of making N-methyl pyrrolidinone (NMP). Aqueous ammonia and succinate is introduced into a vessel and ammonia is adjusted to provide a ratio of ammonia to succinate of less than 2:1. A methylating agent is reacted with succinate at a temperature of from greater than 100° C. to about 400° C. to produce N-methyl succinimide which is purified and hydrogenated to form NMP. | 2011-10-27 |
20110263875 | Production Process of Glycolide - The invention provides a production process of glycolide comprising the respective steps of: Step 1 of heating a mixture containing a glycolic acid oligomer and a high boiling polar organic under normal or reduced pressure to reflux the mixture and at that time, conducting a total reflux operation in a reflux time within a range of 0.1 to 20 hours under conditions that substantially the whole amount of a distillate distilled out of a reflux system containing the mixture is refluxed into the reflux system; Step 2 of heating the mixture after the total reflux operation or a mixture obtained by adding the high boiling polar organic solvent to a glycolic acid oligomer component recovered from the mixture after the total reflux operation to conduct depolymerization; and Step 3 of collecting glycolide from a co-distillate. | 2011-10-27 |
20110263876 | EXPEDITIOUS SYNTHESIS OF GIBBERLLIN A5 AND ESTERS THEREOF - An expeditious synthesis of gibberellin A | 2011-10-27 |
20110263877 | Cycloalkylmethylamines - The present invention provides novel cycloalkylmethylamine analogs, and methods of preparing cycloalkylmethylamine analogs. The present invention also provides methods of using cycloalkylmethylamine analogs and compositions of cycloalkylmethylamine analogs. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications. | 2011-10-27 |
20110263878 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL - The present invention relates to a process for preparation of a delta-9-tetrahydrocannabinol compound or derivative thereof involving treating a first intermediate compound with an organoaluminum-based Lewis acid catalyst, under conditions effective to produce the delta-9-tetrahydrocannabinol compound or derivative thereof. Another aspect of the present invention relates to a process for preparation of a cannabidiol or cannabidiolate compound involving reacting a first starting compound with a second starting compound in the presence of a metal triflate catalyst, under conditions effective to form the cannabidiol or cannabidiolate compound. The present invention also relates to a compound of the formula: | 2011-10-27 |
20110263879 | ZWITTERIONIC PHOSPHONIUM SALTS - A zwitterionic phosphonium salt of Formula I: wherein n is 0 or 1; R is H or SO | 2011-10-27 |
20110263880 | EFFICIENT METHOD FOR PREPARING 2,5-DIMETHYLFURAN - The present disclosure provides methods to make liquid fuels from renewable, carbon neutral precursors. Specifically, methods to prepare 2,5-dimethylfuran from a source of fructose or other carbohydrates using a one-pot synthesis are provided. In some embodiments, the disclosed methods avoid the isolation of intermediates, and employ “green” reagents like formic acid and acetic acid. | 2011-10-27 |
20110263881 | METHOD OF SEPARATING SOLID SALT FROM EPOXY RESIN SOLUTIONS - Use a centrifuge, especially a peeler centrifuge, that has a coarse salt particle layer deposited on its screen to effect recovery of an epoxy resin, especially a liquid epoxy resin, from a product slurry, which epoxy resin has a lower residual salt content than an epoxy resin recovered without use of the coarse salt particle layer. | 2011-10-27 |
20110263882 | METHOD OF PRODUCING EPOXY COMPOUNDS - Provided is a method of efficiently producing an epoxy compound from an allyl ether having an aromatic ring under mild conditions by using hydrogen peroxide as an oxidizing agent without using an organic solvent. The method of producing an epoxy compound comprises reacting an allyl ether having an aromatic ring with hydrogen peroxide to epoxidize a carbon-carbon double bond of an allyl group to thereby produce a corresponding epoxy compound having an aromatic ring, wherein water only is used as a solvent without using an organic solvent, and a tungsten compound, and a tertiary amine and/or a quaternary ammonium salt, are used as a reaction catalyst. | 2011-10-27 |
20110263883 | Extraction With Fractionation of Oil and Co-Products from Oleaginous Material - Systems and methods for extracting lipids of varying polarities from oleaginous material. | 2011-10-27 |
20110263884 | Process for Preparing Saturated Branched Chain Fatty Acids - A process for preparing saturated branched chain fatty acids or alkyl esters thereof involving subjecting unsaturated fatty acids having 10 to 25 carbon atoms, alkyl esters thereof or mixtures thereof to a skeletal isomerization reaction in the presence of water or a lower alcohol at a temperature of about 240° C. to about 280° C. using a combination of a stericly hindered Lewis base and zeolite as a Brönsted or Lewis acid catalyst, and isolating saturated branched chain fatty acids or alkyl esters thereof or mixtures thereof from the reaction mixture obtained by the skeletal isomerization reaction. The yield of said saturated branched chain fatty acids is ≧70 wt %. The stericly hindered Lewis base is a tertiary amine or phosphine with linear or branched C1 to C6 alkyl or phenyl groups attached thereto. | 2011-10-27 |
20110263885 | POLYOL ESTERS OF MEDIUM CHAIN FATTY ACIDS AND PROCESS FOR PREPARATION THEREOF - A new class of oleochemical based polyol esters of general formula 1 are prepared by esterification of different polyols having 5-6 carbon atoms and 2-4 hydroxyl groups with 10-undecenoic acid or/and undecanoic acid with a hydroxyl value of ≦1.0 mg KOH/g. Wherein R | 2011-10-27 |
20110263886 | METHODS OF PRODUCING BIOFUELS, CHLOROPHYLLS AND CAROTENOIDS - A method for producing biofuels along with valuable food and neutraceutical products is provided. A method of making biofuels includes dewatering substantially intact algal cells to make an algal biomass, extracting neutral lipids along with carotenoids and chlorophylls from the algal biomass, and separation of the carotenoids and chlorophylls using adsorption or membrane diafiltration or other methods. The remaining neutral lipids are esterified with a catalyst in the presence of an alcohol. The method also includes separating a water soluble fraction comprising glycerin from a water insoluble fraction comprising fuel esters and distilling the fuel esters under vacuum to obtain a C16 or shorter fuel esters fraction, a C16 or longer fuel ester fraction, and a residue comprising omega-3 fatty acids esters and remaining carotenoids. The method further includes hydrogenating and deoxygenating at least one of (i) the C16 or shorter fuel esters to obtain a jet fuel blend stock and (ii) the C16 or longer fuel esters to obtain a diesel blend stock. | 2011-10-27 |
20110263887 | CYCLIC POLYORGANOSILOXANESILAZANE AND METHOD OF PRODUCING SAME - A novel cyclic polyorganosiloxanesilazane, which is a siloxane oligomer having satisfactory reactivity, and is useful as a silylating agent that does not generate reaction residues. Also, a method of producing the cyclic polyorganosiloxanesilazane. The cyclic polyorganosiloxanesilazane is represented by general formula (1) shown below: | 2011-10-27 |
20110263888 | Cycloalkylmethylamines - The present invention provides novel cycloalkylmethylamine analogs, and methods of preparing cycloalkylmethylamine analogs. The present invention also provides methods of using cycloalkylmethylamine analogs and compositions of cycloalkylmethylamine analogs. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications. | 2011-10-27 |
20110263889 | PROCESSES FOR THE PREPARATION OF ESTERS - The invention relates to a process for the preparation of synthetic pyrethroid insecticides. The process involves coupling of carboxylic acid (IV) with an alcohol (V) in the presence of a catalyst wherein R1, R2, R3 and Ar are defined in the specification. | 2011-10-27 |
20110263890 | Amide Gellant Compounds With Aromatic End Groups - A compound of the formula | 2011-10-27 |
20110263891 | Catalyst for Gas Phase Hydrogenation of Carboxylic Acids Having a Support Modified with a Reducible Metal Oxide - A process for selective formation of ethanol from acetic acid includes contacting a feed stream containing acetic acid and hydrogen at an elevated temperature with catalyst comprising platinum and tin on a high surface area silica promoted with calcium metasilicate. Selectivities to ethanol of over 85% are achieved at 280° C. with catalyst life in the hundreds of hours. | 2011-10-27 |
20110263892 | PROCESS FOR PREPARING AN ISOCYANATE - The present invention relates to a process for preparing an isocyanate, comprising hydrogenating a mixture (Gi) comprising an amine in the presence of a hydrogenation catalyst comprising copper to obtain a mixture (Gii) comprising the amine, and reacting the mixture (Gii) with phosgene to obtain a mixture (Giii) comprising the isocyanate. The present invention further relates to the isocyanate preparable by this process. | 2011-10-27 |
20110263893 | PRODUCTS, PROCESS FOR PRODUCING THEM, AND THEIR USE - Process for producing products which comprises
| 2011-10-27 |
20110263894 | METHOD FOR COMPRESSING GASES CONTAINING HYDROGEN SULFIDE - A process for compressing a hydrogen-sulfide-comprising gas stream, which comprises
| 2011-10-27 |
20110263895 | RECOVERY OF ACETIC ACID FROM WOOD EXTRACTS - In a process for recovering acetic acid from a wood extract, an aqueous wood extract is provided that contains acetic acid and dissolved hemicellulose containing uronic acid. A water insoluble solvent containing an extractant for the acetic acid is also provided. In a preferred embodiment, the solvent is undecane and the extractant is trioctylphosphine oxide. The wood extract is contacted with the solvent and extractant in order to extract the acetic acid from the wood extract. The acetic acid is then recovered from the solvent and extractant. | 2011-10-27 |
20110263896 | Process for Enantioseparation of Chiral Systems with Compound Formation Using Two Subsequent Crystallization Steps - Method for enantioseparation of a chiral system with compound formation comprising a pair of enantiomers. The method comprises the steps of: placing the chiral system to be processed, which is optically enriched by a target enantiomer, in the 3-phase region of the ternary phase diagram of chiral compound forming systems to achieve the establishment of the solid/liquid phase equilibria; phase-separating the liquid and solid phase formed by the placing step; shifting the eutectic composition of the remaining liquid towards a lower eutectic composition (x | 2011-10-27 |
20110263897 | PREPARATION METHOD OF HIGH-PURITY L-CARNITINE - The present invention relate to a preparation method of high-purity L-carnitine which belongs to an important technique of quality control in different steps of chiral medicine production. The method comprises the following steps of: monitoring the content of the L-isomer impurity in chiral material S-epichlorohydrin by gas chromatography and chiral column and controlling the content of the L-isomer impurity in chiral raw material in the definite range; monitoring and controlling the specific optical rotation of the chiral intermediate L-3-chloro-2-hydroxy-N,N,N-trimethyl-propanaminium in the definite ranges using a polarimeter; monitoring the content of the R-isomer in the intermediate L-3-cyano-2-hydroxy-N,N,N-trimethyl-propanaminium using derivation agent (+)α-methyl-6-methoxy-2-naphthaleneaceyl chloride by HPLC and controlling the content of the isomer in the intermediate in the definite range; and measuring the final product L-carnitine using derviation agent (+)α-methyl-6-methoxy-2-naphthaleneaceyl chloride by HPLC. This method gives the high-purity L-carnitine in which the content of L-isomer may be more than 97% and that of R-isomerless than 2%. | 2011-10-27 |
20110263898 | ETHER-AMIDE COMPOUNDS AND PREPARATION AND USES THEREOF - Novel ether-amide compounds having the formula R | 2011-10-27 |
20110263899 | Novel Process for the Preparation of Amino Acid Derivatives - The present patent application relates to an alternative process for the preparation of amino derivatives. In particular, the present application relates to an improved process for the manufacture of Lacosamide (LCM), (R)-2-acetamido-N-benzyl-3-methoxypropion-amide, which is useful as an anticonvulsive drug. In a particular aspect, the present invention relates to a process of manufacture of optically enriched (R)-2-acetamido-N-benzyl-3-methoxypropion-amide (I) comprising resolution of 2-acetamido-N-benzyl-3-methoxypropion-amide (II). | 2011-10-27 |
20110263900 | PROCESS FOR MANUFACTURING ADAMANTANE DERVATIVES WITH HIGH YIELD - The present invention pertains to process for the amidation of a substituted 1-bromo-adamantane comprising a step (0) of reacting a substituted adamantane with an excess of bromine to obtain a 1-bromo-adamantane and a step (i) of reacting said substituted 1-bromo-adamantane with an amide, wherein the substituted 1-bromo-adamantane is used in the form of a mixture comprising bromine as obtained in step (0), wherein in step (0) a bromine:substituted adamantane molar ratio of from [2.5:1] to less than [5:1] is employed. | 2011-10-27 |
20110263901 | Process of Preparation of Proguanil - Disclosed herein is the process for the preparation of 1-(4-chlorophenyl)-5-isopropyl-biguanide hydrochloride (Proguanil hydrochloride), Formula-I, an antimalarial agent. | 2011-10-27 |
20110263902 | PROCESS FOR PREPARING 4,4'-DICHLORODIPHENYL SULFONE - The invention relates to a process for preparing 4,4′-dichlorodiphenyl sulfone, comprising the reaction of monochlorobenzene and liquid sulfur trioxide, wherein the liquid sulfur trioxide used has a boron content of at most 100 ppm based on the total weight of the sulfur trioxide used, including all secondary components. | 2011-10-27 |
20110263903 | PROCESS FOR PREPARING 4,4'-DICHLORODIPHENYL SULFONE - The invention relates to a process for preparing 4,4′-dichlorodiphenyl sulfone proceeding from monochlorobenzene, wherein the content in the monochlorobenzene used of hydrocarbons having from 5 to 8 carbon atoms is at most 100 ppm; based on the total weight of the monochlorobenzene used, including the secondary components. | 2011-10-27 |
20110263904 | YIELD-EFFICIENT PROCESS FOR THE PRODUCTION OF HIGHLY PURE 2-METHYL-1,4-NAPHTHOQUINONE AND ITS DERIVATIVES - The present invention discloses a process for the production of 2-methyl-1,4-naphthoquinone and its bisulfite adducts, comprising the following steps:
| 2011-10-27 |
20110263905 | MULTISTAGE CUMENE OXIDATION - The present invention concerns a process for oxidizing cumene to cumene hydroperoxide using an oxygen containing gas, preferably air, which process comprises—conducting a cumene feed and an oxygen containing gas feed to at least the first oxidation reactor in a series of 3-8 reactors, thereby forming an oxidation mixture, and conducting the formed oxidation mixture from one reactor to the next, preferably after an oxidation reaction has taken place, wherein—the reactors comprise at least one lower pressure oxidizer ( | 2011-10-27 |
20110263906 | METHOD OF PRODUCING REDUCED COENZYME Q10 CRYSTALS WITH EXCELLENT HANDLING PROPERTIES - The present invention provides a method of producing reduced coenzyme Q | 2011-10-27 |
20110263907 | PROCESS FOR PREPARING 1,6-HEXANEDIOL - A process for preparing 1,6-hexanediol from a carboxylic acid mixture which comprises adipic acid, 6-hydroxycaproic acid and small amounts of 1,4-cyclohexanediols and is obtained as a by-product of the oxidation of cyclohexane to cyclohexanone/cyclohexanol with oxygen or oxygen-comprising gases by water extraction of the reaction mixture, by esterification and hydrogenation to hexanediol, which comprises
| 2011-10-27 |
20110263908 | METHOD FOR PRODUCING GLYCEROL - The present invention provides a method for producing glycerol, including transesterifying an oil-and-fat with an alcohol in the presence of a solid catalyst to obtain a glycerol product liquid and subjecting the glycerol product liquid to adsorption treatment with an ion-exchange resin. | 2011-10-27 |
20110263909 | Method For Reprocessing Aircraft De-Icing Agents Comprising Glycol - The invention relates to a method for reprocessing aircraft de-icing agents comprising glycol, wherein (1) the used aircraft de-icing agents are collected in a suitable device, (2) the used aircraft de-icing agent is subsequently brought to a propylene glycol content of between 55 and 75% by weight without prior separating of solid or suspended impurities by expelling water at increased temperature, (3) the concentrated used aircraft de-icing agent thus obtained is transported to a central reprocessing system, where the same is subjected to a fine distillation, and wherein (4) propylene glycol is produced as a distillate of the fine distillation. | 2011-10-27 |
20110263910 | Copper Catalysts for Making Ethanol from Acetic Acid - Catalysts and processes for forming copper catalysts for use in hydrogenating acetic acid to form ethanol. The catalyst may also comprise a second metal selected from the group consisting of chromium, palladium, platinum, rhodium, ruthenium, silver, tungsten, vanadium, and zinc. | 2011-10-27 |
20110263911 | Direct and Selective Production of Ethanol from Acetic Acid Utilizing a Platinum/ Tin Catalyst - A process for the selective production of ethanol by vapor phase reaction of acetic acid over a hydrogenating catalyst composition to form ethanol is disclosed and claimed. In an embodiment of this invention reaction of acetic acid and hydrogen over a platinum and tin supported on silica, graphite, calcium silicate or silica-alumina selectively produces ethanol in a vapor phase at a temperature of about 250° C. | 2011-10-27 |
20110263912 | Control Of Kinetic Decomposition In Mixed Conducting Ion Transport Membranes - Mixed conducting ion transport membrane comprising a multi-component metallic oxide compound represented by the formula Ln | 2011-10-27 |
20110263913 | DEVICE AND METHOD FOR CONTINUOUS HYDRATE PRODUCTION AND DEHYDRATION BY CENTRIFUGAL FORCE - Disclosed herein is an apparatus and method for continuously producing and dehydrating gas hydrates. The apparatus includes a gas source, a water source, a reactor, a spinning wheel, and a centrifugal separator. The gas source and the water source are connected to the reactor. Gas and water are respectively supplied from the gas source and the water source into the reactor and react with each other in the reactor to form gas hydrate slurry. The spinning wheel and the centrifugal separator are provided in the reactor. The spinning wheel supplies the formed gas hydrate slurry to the centrifugal separator. The centrifugal separator dehydrates the gas hydrate slurry. Water removed from the gas hydrate slurry by the dehydration of the centrifugal separator is re-supplied into the reactor. | 2011-10-27 |
20110263914 | Synthetic Fluids and Methods of Manufacture - A method for producing synthetic fluids from TGFA's harvested from genetically modified seed crops in which all of the fatty acids in the TGFA's from the seeds of a crop have the same carbon atom chain length, preferably C12 or C14, and the synthetic fluids produced by the method. The TGFA's are hydroprocessed to cleave the fatty acids from the glycol backbone and to hydrodeoxygenate and isomerize the fatty acids to form single carbon chain length isoparaffins having a controlled degree of branching with minimum cracking. Controlled mixtures of hydrocarbon components, in which each hydrocarbon component of the mixture has a different single carbon atom chain length, are produced. The relative ratios of the single carbon atom number hydrocarbons in the mixture are selected to optimize the characteristics of the synthetic fluid product for a given application, if the end product is an SDF, the severity of the hydrotreatment is controlled such that the degree of cracking is minimized and the isomers generated are primarily monomethyl isoparaffins. If the end product is a jet fuel blend stock, the hydrotreatment is somewhat more severe in order to generate multiple branched isomers that have improved aerobic biodegradability and low temperature properties. The degree of hydrotreatment is controlled to limit the degree of branching in order to preserve the required thermal and oxidative stability properties, and to minimize cracking. | 2011-10-27 |
20110263915 | PROCESS FOR UPGRADING HYDROCARBONS - A process for upgrading hydrocarbons comprising removal of C5 hydrocarbons from a feedstock, metathesizing said C5 hydrocarbons to C6+ and C4− hydrocarbons, and upgrading said C4− hydrocarbons is disclosed absent any dehydrogenation. | 2011-10-27 |
20110263916 | CARBOHYDRATES UPGRADING AND HYDROTREATING TO HYDROCARBONS - Technologies to convert biomass to liquid hydrocarbon fuels are currently being developed to decrease our carbon footprint and increase use of renewable fuels. Since sugars/sugar derivatives from biomass have high oxygen content and low hydrogen content, coke becomes an issue during zeolite upgrading to liquid hydrocarbon fuels. A process was designed to reduce the coke by co-feeding sugars/sugar derivatives with a saturated recycle stream containing hydrogenated products. | 2011-10-27 |
20110263917 | Process for Producing Propylene and Aromatics from Butenes by Metathesis and Aromatization - The invention is for a process for producing propylene and hexene (along with ethylene, pentenes, product butenes, heptenes and octenes) by metathesis from butenes (iso-, 1- and cis and trans 2-) and pentenes and then aromatizing the hexenes (along with higher olefins, such as heptenes and octenes) to benzene (along with toluene, xylenes, ethylbenzene and styrene). Since the desired products of the metathesis reaction are propylene and hexene, the feed to the metathesis reaction has a molar ratio for 1-butene:2-butene which favors production of propylene and 3-hexene with the concentration of hexenes and higher olefins in the metathesis product being up to 30 mole %. An isomerization reactor may be used to obtain the desired molar ratio of 1-butene:2-butene for the feed composition into the metathesis reactor. After the metathesis reaction, of hexene and higher olefins are separated for aromatization to benzene and other aromatics. | 2011-10-27 |
20110263918 | Xylene Isomerization Process and Catalyst Therefor - The invention concerns a xylenes isomerization process for the production of equilibrium or near-equilibrium xylenes. The process utilizes a catalyst comprising HZSM-5 or MCM-49 and process conditions including a temperature of less than 295° C. and a pressure sufficient to maintain the xylenes in liquid phase. In embodiments, the process can be operated in a continuous mode with ppm levels of dissolved H | 2011-10-27 |
20110263919 | Chemical Reactor Operation - A method of operation of one or more chemical reactors, wherein each reactor defines first flow channels for a chemical reaction process in proximity to second flow channels for heat transfer, and each reactor is provided with fluid connections for bringing about flows of respective fluids through the first and second flow channels, involves the steps of shutting down the flows of fluids through at least one of the first and second flow channels, and then changing the fluid connections, and then reopening the fluid connections. There is no change in the chemical reaction process performed by the reactors. The change to the fluid connections is preferably such as to achieve a flow reversal. This may involve turning the reactor itself around, or changing the arrangement of ducts connected to the reactor. This changes the thermal stress distribution within the reactor, and can consequently increase the reactor's operational lifetime. | 2011-10-27 |
20110263920 | ADVANCED METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS - The present invention relates to methods for treating cell proliferation disorders comprising (1) administering to the subject at least one activatable pharmaceutical agent that is capable of activation by a simultaneous two photon absorption event and of effecting a predetermined cellular change when activated, (2) administering at least one plasmonics-active agent to the subject, and (3) applying an initiation energy from an initiation energy source to the subject, wherein the plasmonics-active agent enhances or modifies the applied initiation energy, such that the enhanced or modified initiation energy activates the activatable pharmaceutical agent by the simultaneous two photon absorption event in situ, thus causing the predetermined cellular change to occur, wherein said predetermined cellular change treats the cell proliferation related disorder, and the use of plasmonics enhanced photospectral therapy (PEPST) and exiton-plasmon enhanced phototherapy (EPEP) in the treatment of various cell proliferation disorders, and the PEPST and EPEP agents and probes | 2011-10-27 |
20110263921 | Patterned Denervation Therapy for Innervated Renal Vasculature - A renal denervation apparatus includes a treatment element dimensioned for deployment on or within a renal artery of a patient. The treatment element comprises a predefined pattern arranged to complete at least one revolution of the treatment element. The apparatus includes a treatment source. The treatment source and treatment element are configured to cooperatively facilitate communication of an agent from the treatment source to the pattern arrangement of the treatment element. The treatment element is configured to deliver denervation therapy using the agent via the pattern arrangement to one or more regions of the renal artery adjacent the pattern arrangement, such that at least one complete revolution of the renal artery is subjected to the denervation therapy. | 2011-10-27 |
20110263922 | METHOD, DEVICE AND APPARATUS SYSTEM FOR PROSTATE CANCER THERAPY - In a method, a device and an apparatus system for therapy of prostate cancer, in the course of a therapy session the prostate of a patient is subjected at different locations to a diagnostic examination with regard to the presence of a tumor, and in the case of a positive diagnosis the prostate is therapeutically treated at the corresponding location during the therapy session. The device has a hollow needle, a biopsy needle carrying an extraction element at its forward end that serves to extract a tissue sample, and a therapy element serving to therapeutically act at a location of the prostate. The biopsy needle or the optical waveguide and the therapy element are designed so that they can be inserted into the hollow needle. The apparatus system includes a diagnostic unit and a therapy unit for focal therapy treatment of the prostate, the diagnostic unit including a device for histological assessment of prostate tissue. | 2011-10-27 |
20110263923 | SPACERS FOR USE IN BRACHYTHERAPY, RADIOTHERAPY, AND OTHER MEDICAL THERAPY - Spacers for use in brachytherapy, radiotherapy, and other medical therapy, which can be used to improve a patient's outcome, assist in treating difficult cases and/or combine multiple modalities that are currently performed separately into a single procedure. In accordance with an embodiment, a spacer is formed of an encapsulating material in a generally cylindrical or elongated shape. One or more regions are formed within the spacer for receiving and retaining therapeutic loads, such as radiation sources and/or pharmaceutical therapeutic loads, and/or any other substances that a physician might select to treat a patient, such as drug liquids, powder or particles (e.g., microparticles or nanoparticles), with the particles or powders combined with binders, such as polyacrylamide, that are selected to retain and gradually disperse the powder or particles at a desired rate. Such regions can be formed at various locations within the spacer, and can have various shapes depending on the particular design and intended usage, including, for example, bores, end cavities, wells, ports, slots and/or pockets. The outer surface of the encapsulating material can optionally include one or more fins, ribs or other physical protuberances or features that improve the fixity of the spacer when implanted within a patient's body. When implanted into the body, the spacer helps provide proper placement and spacing such as symmetrical and/or asymmetrical placement and spacing of the radiation sources and/or pharmaceutical therapeutic loads. | 2011-10-27 |
20110263924 | FUNCTIONALIZED MAGNETIC NANOPARTICLE ANALYTE SENSOR - A method and system for simply and efficiently determining quantities of a preselected material in a particular solution by the placement of at least one superparamagnetic nanoparticle having a specified functionalized organic material connected thereto into a particular sample solution, wherein preselected analytes attach to the functionalized organic groups, these superparamagnetic nanoparticles are then collected at a collection site and analyzed for the presence of a particular analyte. | 2011-10-27 |
20110263925 | Pulsed Magnetic Therapy Device - A device for treating diseases and chronic ailments of the human body by inducing powerful, short duration magnetic pulses in close proximity to a region of the body. The device comprises an electromagnetic coil or inductor energized by an electric circuit and a power source, pulsed between 1 and 25 pulses per second for therapeutic means and use as an alternative medical treatment. The device comprises an electric circuit that transmits pulsating current to an induction coil placed within a handheld stylus device for introducing a high energy, pulsed magnetic field to target locations on the body. The stylus is placed against the human body and introduces the pulsating magnetic field into and through body tissue, bone and the bloodstream. The stylus is completely noninvasive and provides a means to direct magnetic energy to a specific part of the body. The device is an advancement in the art, and one that provides increased magnetic energy and pulse frequency without the use of Xenon flash tubes that consume large quantities of power. | 2011-10-27 |
20110263926 | METHOD AND SYSTEM FOR SEARCH/TREATMENT OF TINNITUS - A method and a system for search/treatment of tinnitus are disclosed. The method includes outputting a tinnitus search interface, which comprises several response regions corresponding to the different frequency bands within audible frequency range of human beings, outputting an acoustic signal corresponding to the response region selected by a user, and storing the frequency information corresponding to the user's tinnitus frequency as a tinnitus frequency band. Accordingly, tinnitus may be rapidly diagnosed and treated. | 2011-10-27 |
20110263927 | MEDICAL SLINGS - A sling in accordance with the invention includes a synthetic material and a non-synthetic material positioned adjacent thereto. The non-synthetic material may be wrapped around or may be attached to the synthetic material. Additionally, the non-synthetic material may include slits. Methods for making such slings are also described. | 2011-10-27 |
20110263929 | SYSTEM AND METHOD FOR DETERMINING AN ADJUSTMENT TO A GASTRIC BAND BASED ON SATIETY STATE DATA AND WEIGHT LOSS DATA - A system and method for determining an adjustment to a gastric band, and more specifically to determining an adjustment to a gastric band based on satiety state data and weight loss data. The gastric band information system can determine an adjustment of the gastric band using a gastric band adjustment algorithm. The gastric band information system can wirelessly transmit the adjustment to the gastric band. The gastric band information system can receive gastric band data, weight data, glucose data, and/or blood pressure data and display a gastric band chart, a weight chart, and/or a blood pressure chart. The gastric band information system can also receive gastric band implantation data, patient data, and/or any other medical data. The various data can be received from a computer or medical devices in a wired or wireless manner. | 2011-10-27 |
20110263930 | Device and method for vaginal sacrocolpopexy - A surgical procedure for repairing vaginal prolapse, including apical descent (vaginal vault or uterine descensus), cystocele and/or rectocele, avoids bladder injury, the need for laparoscopic suturing, and difficulties in tensioning the mesh used to hold the vagina in the correct anatomical position, and can be practiced with off the shelf components. The procedure typically comprises exposing a female patient's peritoneum; making a peritoneal incision (e.g. over the patient's sacrum); mobilizing the peritoneum; incising the patient's vagina and attaching the anterior and posterior surfaces of a first (e.g. generally rectangular) mesh component, with a truncated stem and first locking element, to the apex of the patient's vagina; passing a mesh base component having a second locking element at a distal end, and a proximal end, underneath the peritoneum; moving the first and second locking elements together into locking relationship; anchoring the mesh base (e.g. to the sacrum, so that the mesh components suspend the vaginal apex from the sacrum); and closing the peritoneal incision. Particular mesh components with locking elements, and a surgical spreader for use in the procedure, are desirable. | 2011-10-27 |
20110263931 | ELASTIC SLING SYSTEM AND RELATED METHODS - The invention provides, in various embodiments, systems, devices and methods relating to adjustable length implantable sling assemblies for providing support to anatomical locations. In certain embodiments, the sling includes at least one elastic member to aid in the placement and tensioning of the sling. | 2011-10-27 |
20110263932 | PELVIC FLOOR REPAIR IMPLANTS AND METHODS - The invention generally relates to surgically implantable supportive slings. More specifically, in various embodiments, the invention is directed to sling assemblies for pelvic floor repair that utilize one or more materials, attached without a mechanical fixation device, and related methods of use and fabrication. | 2011-10-27 |
20110263933 | RESILIENT SUPPORT - Disclosed is a modular endoscope system in which a plurality of connecting pieces, tools, and cannulas which are selected according to the use thereof are assigned to a single optics. The connecting pieces and the cannulas are preferably designed for single use, so that merely the optics has to be decontaminated. | 2011-10-27 |
20110263934 | CATHETER HAVING TRI-AXIAL FORCE SENSOR - A catheter for diagnosis or treatment of a vessel or organ is provided in which a flexible elongated body includes a tri-axial force sensor formed of a housing and a plurality of optical fibers associated with the housing that measure changes in the intensity of light reflected from the lateral surfaces of the housing resulting from deformation caused by forces applied to a distal extremity of the housing. A controller receives an output of the optical fibers and computes a multi-dimensional force vector corresponding to the contact force. | 2011-10-27 |
20110263935 | INTUBATION SYSTEMS AND METHODS BASED ON AIRWAY PATTERN IDENTIFICATION - An intubation system of the present disclosure intubates based on an airway pattern indicating a trachea opening. The airway pattern is determined from analysis of airway data detected by a trachea identifying device disposed on a moveable guide stylet of the intubation system. A navigation element is generated based on the airway pattern. In one embodiment, the airway pattern is a gas exchange pattern indicating a trachea opening. In another embodiment, the trachea opening transition pattern is a topographic pattern indicating a trachea opening. The guide stylet is capable of moving in a plurality of degrees of freedom in the airway following the guidance from the navigation element. | 2011-10-27 |
20110263936 | DEVICES AND METHODS FOR PREDICTING AND PREVENTING RESTENOSIS - The present invention relates to methods and devices for predicting restenosis, and for treating atherosclerosis to prevent or reduce the incidence of restenosis. Methods of predicting restenosis in a stenosed peripheral artery may include quantitative histology of the vessel. For example, a method of treating a stenosed artery (and particularly a peripheral artery) may include the steps of determining a level of hypercellularity and one or more of the lipid-richness and extent of inflammatory cell inclusion in the tissue. An index of restenosis based on the hypercellularity and lipid richness and/or extent of inflammatory cell inclusion in the tissue may be determined. Systems for treating or preventing restenosis may include one or more imaging modalities for imaging tissue regions and determining the level of hypercellularity and one or more of the degree of lipid-richness and the extent of inflammatory cell inclusion in the tissue region. | 2011-10-27 |
20110263937 | RIGID ENDOSCOPE - The rigid endoscope has a shank-like middle part, on which a handle connects on a proximal side and which on a distal side includes a distal part with an optics window. The handle is arranged offset or obliquely to a longitudinal axis of the middle part, as well as of the distal part, in order to provide free space in the region of the handle of the working instrument as well as on the distal side of the tool. | 2011-10-27 |
20110263938 | MULTI-CAMERA ENDOSCOPE - A multi-camera endoscope which includes an elongated shaft terminating with a tip section turnable by way of a bending section, wherein the tip section includes: a front-pointing camera and a discrete front illuminator associated therewith; a front fluid injector configured for cleaning at least one of said front-pointing camera and said discrete front illuminator; a side-pointing camera and a discrete side illuminator associated therewith; a side fluid injector configured for cleaning at least one of said side-pointing camera and said discrete side illuminator; a working channel configured for insertion of a surgical tool; and a pathway fluid injector for inflating and/or cleaning a body cavity into which the endoscope is inserted. | 2011-10-27 |
20110263939 | WATER BOTTLE ADAPTER FOR COUPLING AN ENDOSCOPE TO A WATER BOTTLE - An adapter for coupling a disposable water bottle to an endoscope including a cap manufactured from a thermoplastic elastomer material. The cap is removably secured to an associated water bottle. The cap includes a first port and a second port. The adapter further includes a scope connector manufactured from the thermoplastic elastomer and/or thermoset elastomer having a first scope connector port and second scope connector port, wherein the scope connector is configured to be frictionally coupled to an endoscope. A first supply tube couples to the first port of the cap and the first scope connector port and a second supply tube coupled to the second port of the cap and the second scope connector port. By using a thermoplastic elastomer and/or thermoset elastomer material, a simplified adapter is provided, which substantially reduces design and manufacturing costs. | 2011-10-27 |
20110263940 | ENDOSCOPE APPARATUS - An endoscope apparatus comprising an irradiating section that irradiates the target with the irradiation light containing light in a first wavelength region, which reaches a first penetration depth within the target, and light in a second wavelength region, which reaches a second penetration depth within the target; an optical system that focuses, at substantially the same position in a direction of an optical axis thereof, first returned light from a position at a distance of the first penetration depth from a surface of the target in a direction of emission of the light in the first wavelength region and second returned light from a position at a distance of the second penetration depth from the surface of the target in a direction of emission of the light in the second wavelength region; and a light receiving section that receives the first returned light and the second returned light. | 2011-10-27 |
20110263941 | ENDOSCOPE DESIGNS AND METHODS OF MANUFACTURE - Various embodiments of the present invention comprise endoscopes for viewing inside a cavity of a body such as a vessel like a vein or artery. These endoscopes may include at least one solid state emitter such as a light emitting diode (LED) that is inserted into the body cavity to provide illumination therein. Certain embodiments of the invention comprise disposable endoscopes that can be fabricated relatively inexpensively such that discarding these endoscopses after a single use is cost-effective. The endoscope may comprise a lens holder on a distal end of the endoscope for collection of light reflected from surfaces within the body in which the endoscope is inserted. This lens holder may have an inner cavity through which light passes along an optical path. Reflective surfaces on sidewalls of the inner cavity may direct light along this optical path. The endoscope may further comprise an elongated support structure for supporting a plurality of lenses disposed along the optical path. This optical path may lead to a detector onto which images are formed. | 2011-10-27 |
20110263942 | ENDOSCOPE APPARATUS - The present invention discloses an endoscope apparatus comprising a tube body, a cover, a first image capture module, a second image capture module and a connecting tube. The first image capture module captures an image with a first view, and the second image capture module captures an image with a second view. A first flexible printed circuit board (PCB) is disposed inside the tube body, and a second flexible PCB is disposed inside the connecting tube. The connecting tube is connected with the tube body via the connecting between the first flexible PCB and the second flexible PCB, so as to transmit the images captured by the first image capture module or the second image capture module. | 2011-10-27 |
20110263943 | ENDOSCOPE APPARATUS - An endoscope apparatus that captures images of a target using returned light from the target irradiated with irradiation light. The endoscope apparatus comprises a first optical system that has an axial chromatic aberration and respectively focuses light in different wavelength regions contained in the irradiation light at different positions on an optical axis thereof; a second optical system that focuses first returned light in a different wavelength region than light contained in the irradiation light and second returned light in a different wavelength region than the first returned light at substantially the same position on an optical axis thereof, the first returned light and the second returned light being returned from focal positions of the irradiation light focused in the target by the first optical system; and a light receiving section that receives the first returned light and the second returned light focused by the second optical system. | 2011-10-27 |
20110263944 | LAPAROSCOPIC RETRACTOR - A laparoscopic spacer ( | 2011-10-27 |
20110263945 | MINIMALLY INVASIVE INSTRUMENT SET, DEVICES AND RELATED METHODS - A minimally invasive system includes a bone screw and a tissue retractor having distal and proximal end portions and a partial pathway therebetween. The tissue retractor is removably couplable to the bone screw. An instrument has distal and proximal end portions and a hollow cavity and is removably couplable to the tissue retractor. A drive shaft has a diameter less than a diameter of the hollow cavity and is rotatable with respect to the instrument. A counter-torque handle has gripping and an interlock end portions with an instrument interface releasably positioned within the hollow cavity at the proximal end portion thereof and rotatably fixed thereto in an assembled configuration. The interlock end portion also includes an open-ended slot having a width greater than the drive shaft diameter such that the counter-torque handle is movable to and from the assembled configuration while the drive shaft is within the hollow cavity. | 2011-10-27 |
20110263946 | METHOD AND SYSTEM FOR REAL-TIME AND OFFLINE ANALYSIS, INFERENCE, TAGGING OF AND RESPONDING TO PERSON(S) EXPERIENCES - A digital computer and method for processing data indicative of images of facial and head movements of a subject to recognize at least one of said movements and to determine at least one mental state of said subject is provided. The outputting instructions for providing to a user information relating to at least one said mental state. A further processing data reflective of input from a user, and based at least in part on said input, confirming or modifying said determination and generating with a transducer an output of humanly perceptible stimuli indicative of said at least one mental state. | 2011-10-27 |
20110263947 | Extracorporeal Devices and Methods For Facilitating Cessation of Undesired Behaviors - Devices, Methods and Systems are disclosed for assisting patients in behavioral modification and cessation programs aimed at terminating undesired behaviors such as smoking, alcohol use and others. Patient devices with automated patient prompting for self-testing, analysis of test results and data logging are included in a networked system with a specifically designed treatment modality. | 2011-10-27 |
20110263948 | SCORING SYSTEM TO MONITOR NATURAL OR DRUG-MODIFIED DISEASE PROGRESSION IN "EROSIVE OSTEOARTHRITIS" OF THE INTERPHALANGEAL FINGER JOINTS - The present invention provides a scoring system to monitor natural or drug-modified disease progression in erosive inter-phalangeal finger joint osteoarthrits and the use of said scoring system to identify and value drugs with anticatabolic and/or repair promoting potential. | 2011-10-27 |
20110263949 | IMAGE BASED CLINICAL TRIAL ASSESSMENT - A method for assessing a treatment in a trial includes obtaining images generated from image data acquired at different times during a trial time period for a same region of interest of a subject. The treatment is administered to the subject for the trial. The method further includes co-registering the images and mapping the co-registered images to a reference image representing the region of interest. The method further includes generating a trial image of the region of interest showing at least one of structural or functional physiological changes that occurred during the trial time period based on the mapped co-registered images, and displaying the trial image. | 2011-10-27 |
20110263950 | SYSTEMS, DEVICES AND METHODS FOR PREVENTING, DETECTING AND TREATING PRESSURE-INDUCED ISCHEMIA, PRESSURE ULCERS, AND OTHER CONDITIONS - A system for monitoring medical conditions including pressure ulcers, pressure-induced ischemia and related medical conditions comprises at least one sensor adapted to detect one or more patient characteristic including at least position, orientation, temperature, acceleration, moisture, resistance, stress, heart rate, respiration rate, and blood oxygenation, a host for processing the data received from the sensors together with historical patient data to develop an assessment of patient condition and suggested course of treatment. In some embodiments, the system can further include a support surface having one or more sensors incorporated therein either in addition to sensors affixed to the patient or as an alternative thereof. The support surface is, in some embodiments, capable of responding to commands from the host for assisting in implementing a course of action for patient treatment. The sensor can include bi-axial or tri-axial accelerometers, as well as resistive, inductive, capactive, magnetic and other sensing devices, depending on whether the sensor is located on the patient or the support surface, and for what purpose. | 2011-10-27 |
20110263951 | CAPSULE MEDICAL APPARATUS SYSTEM - A capsule medical apparatus system includes: a table for placing a subject thereon along a longitudinal direction; an antenna, which is arranged on a body surface of the subject, for receiving in-vivo information transmitted from a capsule medical apparatus inserted in the subject; a cable for transmitting the in-vivo information received by the antenna; a processing device, which is fixed to a longitudinal end portion of the table, for processing the in-vivo information transmitted via the cable; a rotation mechanism for rotating a connecting portion, at which the cable is connected to the processing device, about a rotation axis lying in the longitudinal direction of the table depending on posture change of the subject. | 2011-10-27 |
20110263952 | INCONTINENCE MANAGEMENT SYSTEM AND DIAPER - An incontinence management system for monitoring wetness in one or more absorbent articles, includes input for receiving one or more sensor signals indicative of a presence of wetness in an absorbent article, processor for processing the one or more sensor signals and for performing an analysis of the signals to characterise wetness events occurring in an absorbent article and user interface for communicating with a user of the system. A mathematical model is used to characterise wetness events, receiving as inputs variables derived from sensor signals and optionally, patient and demographic data. The mathematical model can be configured and/or re-configured utilising observation data obtained while monitoring a patient for wetness. A diaper for use with such as system is also disclosed. | 2011-10-27 |
20110263953 | DEPLOYMENT SYSTEM AND METHOD FOR OPTICAL ANALYTE SENSOR - Embodiments of the invention are directed to a delivery device and method for deploying an optical analyte sensor. The delivery device comprises hollow tubes configured to operate telescopically. The optical sensor is configured to retract and extend from a distal end of the delivery device, by sliding the telescoping tubes with respect to one another. The delivery device may also have a locking mechanism such that the distal end portion of the sensor will extend to a preset locked position beyond the delivery device, e.g., during calibration and deployment. The device is capable of being used to ship, calibrate, and deploy the sensor while maintaining sterility and avoiding exposure to the external environment. | 2011-10-27 |
20110263954 | NONINVASIVE BLOOD GLUCOSE METER - A noninvasive blood glucose meter for testing a blood glucose level of a living organism includes a casing, a printed circuit board and a display device. The casing includes a containing space, and the printed circuit board is installed in the containing space and includes a control unit and a memory unit, and the printed circuit board is electrically coupled to a light emitting device and a light receiving device, and the light emitting device is capable of emitting a light beam, and the light receiving device is provided for receiving a reflected light beam. After the light beam emitted from the light emitting device is entered into the testing living organism, reflected from the testing living organism, and received by the light receiving device, the light beam is passed through and processed by the control unit, and then displayed on a display device and stored in the memory unit. | 2011-10-27 |
20110263955 | Internal Observation Device for Object having Light Scattering Properties, Internal Body Observation Device, Endoscope for Internal Observation and Internal Observation Method - There is provided an inside observation apparatus of an endoscope and the like which can perform an inside observation for irradiating an illumination light to a minute area of a surface of an object (for example, a living tissue) having a light scattering property and detecting a back-scattered light of the illumination light, can increase a detected light amount by a simply and low cost configuration by making an area of a detection region larger than an illumination region, and can reduce a time necessary to detect an body (for example, a blood vessel) to be observed and detect a region deeper than a conventional region. | 2011-10-27 |
20110263956 | DEVICE FOR NON-INVASIVELY MEASURING GLUCOSE - In order to increase the accuracy of non-invasive glucose measurement, the device uses a combination of three non-invasive methods: ultrasonic, electromagnetic and thermal. The non-invasive glucose monitor comprises a Main Unit, which drives three different sensor channels (one per technology), located on an external unit configured as an ear clip attached to the subject's ear lobe. To effect the ultrasonic channel, ultrasonic piezo elements are positioned on opposing portions of the ear clip and thus opposite sides of the ear lobe. For implementation of the electromagnetic channel, capacitor plates are positioned on opposing portions of the ear clip and the ear lobe serves as the dielectric. The thermal channel includes a heater and a sensor positioned on the ear clip in close juxtaposition to the ear lobe. | 2011-10-27 |
20110263957 | TEST SYSTEM - The invention concerns a test system for carrying out blood sugar tests with a diagnostic tape cassette which comprises a windable analytical test tape for detecting an analyte and a cassette housing accommodating the test tape, and a test device which has a device housing for inserting and removing the tape cassette and a measuring unit for detecting the analyte on the test tape. According to the invention it is proposed that the tape cassette can be detachably fastened by positioning elements on a platform mounted in the device housing and that the measuring unit is rigidly attached on the platform or can be engaged therewith. | 2011-10-27 |
20110263958 | SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR - Systems and methods for dynamically and intelligently estimating analyte data from a continuous analyte sensor, including receiving a data stream, selecting one of a plurality of algorithms, and employing the selected algorithm to estimate analyte values. Additional data processing includes evaluating the selected estimative algorithms, analyzing a variation of the estimated analyte values based on statistical, clinical, or physiological parameters, comparing the estimated analyte values with corresponding measure analyte values, and providing output to a user. Estimation can be used to compensate for time lag, match sensor data with corresponding reference data, warn of upcoming clinical risk, replace erroneous sensor data signals, and provide more timely analyte information encourage proactive behavior and preempt clinical risk. | 2011-10-27 |
20110263959 | METHOD OF INPUTTING DATA INTO AN ANALYTE TESTING DEVICE - A meter is provided that includes an improved user interface that enables the user to take a specific action, leading them directly to data input options. Such a user interface could be used to input first selected information, such as whether a test was premeal or postmeal, immediately after receiving a result. Optionally, the user interface may include the ability to add an additional comment after inputting the first selected information. Provision of such a user interface would facilitate simpler capture of the first selected information each time the user performs a test, leading to an enhanced understanding of a patient's level of glycemic control. Designing a user interface to enable first selected information to be entered by a user directly after receiving a result is more likely to engage a patient by making it easy and simple to enter important information. This may enable capture of the information thought to be most pertinent e.g. premeal and postmeal information, enhancing the understanding by patients and their carers of the patient's control. | 2011-10-27 |
20110263960 | Stent Delivery System for Detecting Wall Apposition of the Stent During Deployment - A stent delivery and apposition detecting system includes at least one electrode pair of dissimilar metals mounted on a balloon of a balloon catheter. The electrode pair forms part of an electrochemical cell, and voltage and current generated from the electrochemical cell enables the system to detect when a stent mounted on the balloon achieves proper wall apposition. As the balloon is exposed to different environments, i.e., blood or tissue having different resistances, the electric potential of the electrochemical cell changes and an alert is generated by a feedback circuit to notify a user that the electrodes are in contact with tissue of the vessel wall. In one embodiment, the feedback circuit may be powered by the electrochemical cell. Multiple sets of electrode pairs may be mounted along the circumference and length of the balloon to detect differential contact between the deployed stent and the vessel wall. | 2011-10-27 |
20110263961 | Antenna for Investigating Structure of Human or Animal - A system for investigating the internal structure of a human or animal body. The system comprises one or more antennas for transmitting and/or receiving electromagnetic energy into or from the body, each antenna comprising a slot formed in a conductive element, the slot having an external boundary defined by a substantially closed internal edge of the conductive element. A receiver is configured to detect the effect of the body on the passage of the electromagnetic energy by recording one or more signals. A processor is configured to process the signal(s) in order to generate an output indicative of the internal structure of the body. The antenna slot is a continuous slot with no internal boundary, the boundary of the slot being completely defined by the internal edge of the conductive element. Each antenna may further comprise two or more conductive feed lines, each feed line coupling energy to and/or from a respective part of the slot. | 2011-10-27 |
20110263962 | BRAIN FUNCTION DECODING PROCESS AND SYSTEM - A method of interpreting cognitive response to a stimulus is disclosed. The method includes collecting baseline neural activity data from a subject absent a stimulus. Neural activity data is collected while the subject is being stimulated through exposure to a stimulus. A unique three-dimensional cognitive engram is then plotted representative of cerebral regions of stimulated neural activity caused by the stimulus. A novel graphical representation is plotted in three dimensions to indicate the brain region response unique to that stimulus. | 2011-10-27 |
20110263963 | ACOUSTIC-WAVE MEASURING APPARATUS AND METHOD - An acoustic-wave measuring apparatus includes a holding unit configured to hold a subject and an irradiation unit configured to irradiate the subject with light. An acoustic-wave detecting unit detects acoustic waves generated in the subject due to irradiation with the light; an image pickup unit acquires an image of the subject; and a measurement position on the image acquired by the image pickup unit is designated. A coordinate transforming unit transforms the coordinates of the measurement position on the image to coordinates of a corresponding position on the holding unit; and a position control unit moves at least one of the irradiation unit and the acoustic-wave detecting unit to the corresponding position on the holding unit. | 2011-10-27 |